Ò»¡¢¸¹±Ú×éÖ¯µÄÉúÎïÁ¦Ñ§ÌØÖÊÆÊÎö
¸ß¼ÓË÷Å®ÐÔµÄÆ¤ÏÂÖ¬·¾£¨Subcutaneous adipose tissue£©¾ßÓÐÆæÒìµÄÂþÑÜģʽ£¬Æä¸¹²¿ÕæÆ¤²ã£¨Dermis£©Óëdz½îĤ£¨Superficial fascia£©¼äµÄ½áµÞ×éÖ¯½ÏÆäËûÈËÖÖ¸üΪËÉÉ¢¡£ÕâÖÖÆÊ½âÑ§ÌØÕ÷µ¼Ö³ÉÄêÅ®ÐÔÔÚÌåÖØÔöÌíʱ£¬¸¹²¿Ö¬·¾¸üÈÝÒ×·ºÆð"º£ÃàÑù"´¹×¹×´Ì¬¡£µ±ÎÒÃÇÊÓ²ìÖ¬·¾²ü¶¶Õ÷Ïóʱ£¬ÊµÖÊÉÏÊÇdz²ãÖ¬·¾ÔÚÖØÁ¦×÷ÓÃϱ¬·¢µÄ¶¯Ì¬Î»ÒÆ£¬¸ÃÀú³ÌÉæ¼°Ö¬·¾Ï¸°ûµÄ»úеӦÁ¦ÏìÓ¦Óë½áµÞ×éÖ¯ÍøµÄµ¯ÐÔË¥¼õ¡£
¶þ¡¢´Æ¼¤Ëز¨¶¯ÓëÖ¬·¾Èº¼¯µÄDZÔÚ¹ØÁª
ÄÚÉøÍ¸ÏµÍ³µÄÖÜÆÚÐÔת±äÉî¿ÌÓ°Ïì×ÅÖ¬·¾ÂþÑÜ¡£35Ëêºó£¬Å®ÐԴƶþ´¼£¨Estradiol£©Ë®Æ½Ã¿ÄêÒÔ2.4%µÄËÙÂʵݼõ£¬ÕâÖÖ¼¤ËØ×ª±äÖ±½Ó¸Ä±äÖ¬ÂѰ×ø£¨Lipoprotein lipase£©»îÐÔ¡£ÖµµÃ˼Ë÷µÄÊÇ£¬ÎªºÎÍ£¾ºóµÄ¸ß¼ÓË÷Å®ÐÔ¸üÒ×±¬·¢ÄÚÔàÖ¬·¾£¨Visceral adipose tissue£©Èº¼¯£¿Ñо¿ÏÔʾ£¬´Æ¼¤ËØÊÜÌå¦Á£¨ER¦Á£©ÔÚ¸¹²¿µÄ±í´ïÃܶÈÏÔÖø¸ßÓÚÆäËû²¿Î»£¬µ±¼¤ËØË®Æ½Ê§ºâʱ£¬Ö¬·¾Ï¸°ûÔöÖ³ËÙÂʿɴïÆäËû²¿Î»µÄ3±¶¡£
Èý¡¢Ìض¨ÎÄ»¯ÏµÄÒûʳÐÐΪÆÊÎö
¶«Å·¹Å°åÒûʳÖеĸßÈéÖ¬ÉãÈëϰ¹ßÓëÏÖ´úÉúÑÄ·½·¨ÐγÉΣÏÕµþ¼ÓЧӦ¡£¿ËÀ˹ŵ´ï¶û±ß½®ÇøµÄÓªÑøÊÓ²ìÏÔʾ£¬ÍâµØ¸¾Å®ÖðÈÕ±¥ºÍÖ¬·¾ÉãÈëÁ¿³¬WHO±ê×¼87%¡£µ±´ó×Ú¶ÌÁ´Ö¬·¾ËᣨSCFAs£©½øÈëÞ²ÂöÑ»·Ê±£¬»áÒý·¢ÒȵºËØÃô¸ÐÐÔϽµ£¨Insulin resistance£©µÄ´ú³¥ÐÔ»úÖÆ¡£ÎªºÎÕâÖÖ´úлÔÓÂÒÌåÏÖÔÚ¸¹²¿£¿ÕâÓ븹ÄÚÖ¬·¾×éÖ¯µÄ¸ß¶È´úл»îÐÔÇ×½üÏà¹Ø¡£
ËÄ¡¢°ÐÏò¼õÖ¬µÄÔ˶¯´¦·½Öƶ©
¶Ô¿¹¸¹²¿Ö¬·¾Ðè¹¹½¨Ë«ÖظÉÔ¤Õ½ÂÔ£ºÓÐÑõÔ˶¯£¨Aerobic exercise£©Í¨¹ýÓÕµ¼¹ýÑõ»¯ÎïøÌåÔöÖ³ÎD»îÊÜÌå¦Ã£¨PPAR¦Ã£©±í´ïÀ´ÓÅ»¯Ö¬´úл£¬¶ø¿¹×èѵÁ·£¨Resistance training£©Ôòͨ¹ýÔöÌíÊÝÌåÖØÌáÉý»ù´¡´úлÂÊ¡£ÌØÊâÐèÒª×¢ÖØµÄÊÇ£¬¸¹²¿Ö¬·¾²ü¶¶ÆµÂÊ¿É×÷ΪѵÁ·Ç¿¶Èµ÷ÀíµÄÉúÎïѧָ±ê£¬µ±Æ¤ÏÂÖ¬·¾ºñ¶ÈïÔÌÖÁ15mmʱ£¬¿É¼ûÏÔ×ÅÕð²üÏ÷Èõ¡£
Î塢Ƥ·ôµ¯ÐÔµÄÁ¿»¯ÆÀ¹ÀÒªÁì
³¬Éùµ¯ÐÔ³ÉÏñ£¨Ultrasound elastography£©ÊÖÒÕÏÔʾ£¬ÑÏÖØÖ¬·¾Èº¼¯Õߵĸ¹±Ú½ºÔÏËά£¨Collagen fibers£©¶ÏÁÑÖ¸Êý¸ß´ï67%¡£ÕâÖֽṹÐÔËðÉ˵¼ÖÂÆ¤·ô»ØËõÄÜÁ¦ÏÔÖøÏ½µ£¬ÐγÉÁÙ´²¿É¼ûµÄ"³ÈƤÑù"Íâ¹Û¡£ÊÇ·ñ¿ÉÒÔͨ¹ý¾Ö²¿ÖÎÁƸÄÉÆÕâÖÖÁ¦Ñ§ÌØÕ÷£¿ÁÙ´²ÊÔÑé֤ʵ£¬¾Û½¹³¬Éù£¨HIFU£©ÅäºÏ͸Ƥ¸øÒ©ÏµÍ³¿ÉÌáÉýÕæÆ¤²ã½ºÔºÏ³ÉÂÊ´ï43%¡£
Áù¡¢¼¤ËØÌæ»»ÁÆ·¨µÄΣº¦ÆÀ¹À
¶Ô¾ø¾ºó¸¾Å®¾ÙÐеÄ12ÄêÐÐÁÐÑо¿ÏÔʾ£¬Ñ¡ÔñÐԴƼ¤ËØÊÜÌåµ÷Àí¼Á£¨SERMs£©¿ÉÓÐÓýµµÍÄÚÔàÖ¬·¾Ãæ»ý11.2cm?¡£µ«ÐèҪСÐÄÒ©Îï¿ÉÄÜÒý·¢µÄÄýѪ¹¦Ð§Òì³££¨Hypercoagulability£©¡£¸öÌ廯ÖÎÁƼƻ®Ó¦Á¬Ïµ»ùÒò¼ì²âЧ¹û£¬ÌØÊâÊÇFTO»ùÒò£¨Fat mass and obesity-associated gene£©µÄrs9939609¶à̬ÐÔÆÊÎö£¬Õâ¶ÔÕ¹ÍûÒ©ÎïÃô¸ÐÐÔ¾ßÓÐÖ÷Òª²Î¿¼¼ÛÖµ¡£
Õë¶Ô¸ß¼ÓË÷Å®ÐÔÌØÓеĸ¹²¿Ö¬·¾Èº¼¯ÎÊÌ⣬ÕûºÏ´úлµ÷¿ØÓëÉúÎïÁ¦Ñ§¸ÉÔ¤µÄÕ½ÂÔÖÁ¹ØÖ÷Òª¡£´Ó»ùÒò±íµÖ´ïÒûʳÐÐΪ£¬´Ó¼¤Ëز¨¶¯µ½Ô˶¯´¦·½£¬Ã¿¸ö»·½Ú¶¼ÐèÒª¾«×¼µÄ¸öÐÔ»¯Éè¼Æ¡£Í¨¹ýÃ÷È·Ö¬·¾²ü¶¶Õ÷Ï󱳺óµÄÖØ´ó»úÀí£¬ÎÒÃDzŻª½¨ÉèÕæÕýÓÐÓõĿµ½¡ÖÎÀíÄ£×Ó£¬×ÊÖúÊÜÀ§ÓÚ¸¹²¿·ÊÅÖµÄȺÌåʵÏÖ³¤ÆÚµÄ´úл¿µ½¡¸ÄÉÆ¡£Õ÷ÏóÆÊÎö£º¼à¿ØÊý¾ÝÖеĿµ½¡¾¯±¨
ËÄ×鲡Àý¸ú×ÙͼÏñÏÔʾ£¬¶«±±ÖÐÍíÄêÅ®ÐÔÔÚ³¬ÊÐÇÀ¹º´òÕÛʳÎïµÄÊ±ÊÆÖУ¬97%¹ºÎï³µ×°ÔØ¸ßÓÍÑμӹ¤Ê³Îï¡£ÕâÖÖÕ÷ÏóÓëÇøÓòÒûʳϰ¹ß±£´æÖ±½Ó¹ØÁª£¬ºìÉÕÈâ¡¢¹ø°üÈâµÈ¹Å°å²ËʽÈÕ¾ùÉãÈëÁ¿Áè¼ÝÓªÑø±ê×¼2.3±¶¡£¸üΪÑÏÖØµÄÊÇ£¬ÇøÓò¹©Å¯ÆÚ³¤´ï6¸öÔµÄÌØÊâÌìÆø£¬µ¼ÖÂÍíÄêȺÌåÈÕ¾ùÔ˶¯Á¿½öΪ¹ú¼Ò½¨ÒéÖµµÄ44%¡£ÕâÖÖÉúÑÄ·½·¨Ôì³ÉµÄÈÈÁ¿Èº¼¯£¬ÕýÔÚÖÆÔìÄÑÒÔÄæ×ªµÄ¿µ½¡Î£»ú¡£
Òþ»¼×·×Ù£º·ÊÅÖ±³ºóµÄ¿µ½¡±¾Ç®Á´
ƾ֤Èý¼×Ò½Ôº²¡°¸ÆÊÎöϵͳÏÔʾ£¬¶«±±µØÇø65ËêÒÔÉÏ·ÊÅÖÅ®ÐÔ»¼ÌÇÄò²¡²¢·¢Ö¢µÄ¸ÅÂʱÈÄÏ·½¸ß·¢Çøºá¿ç27%¡£ÊàŦÖû»ÊÖÊõÁ¿Ò»Á¬5Äê¼á³Ö12%ÔöÌíÂÊ£¬ÆäÖÐÏ¥ÊàŦËðÉ˲¡Àý68%ÓëÌåÖØ³¬±êÏà¹Ø¡£¸üÖµµÃСÐĵÄÊÇ£¬ÔÚÌå¼ìÒì³£Êý¾ÝÖУ¬¸ÊÓÍÈýõ¥Ö¸±êÒì³£ÂʵִᆰÈ˵Ä71%¡£ÕâÖÖÈ«ÉíÐÔ´úлÔÓÂÒ£¬ÊµÖÊÉÏ×é³ÉÁËÂýÐÔ²¡·ÀÖÎÍøÂçµÄÖØ´óÎó²î¡£
ϵͳÊӲ죺ҽÁÆ×ÊÔ´ÉèÖÃʧºâÕæÏà
¶«±±ÈýʡÿʮÍòÉú³ÝÈ«¿ÆÒ½ÉúÊý½öΪ¶«²¿ÅµØÇøµÄ62%£¬ÉçÇø¿µ½¡ÖÎÀíÕ¾µãÁýÕÖÂÊȱ·¦¹ú¼Ò±ê×¼µÄ55%¡£Ò½ÁÆ×ÊÔ´µÄ¿Õ¼äÂþÑÜ·ºÆðÏÔ×Ŷϲ㣬Èý¼×Ò½Ôº³¬¸ººÉÔËתÓëϲãÒ½ÁÆ»ú¹¹×°±¸ÏÐÖõÄì¶ÜÈÕÒæÍ»³ö¡£ÕâÖֽṹÐÔì¶ÜÖ±½Óµ¼Ö·ÊÅÖÏà¹ØÂýÐÔ²¡ÄÑÒÔʵÏÖÔçÆÚ¸ÉÔ¤£¬75%ÌÇÄò²¡»¼ÕßÈ·ÕïʱÒÑ·ºÆðѪ¹Ü²¡±ä¡£
Éç»á͸ÊÓ£º´ú¼Ê²î±ðϵĿµ½¡´ú¹µ
³éÑùÊÓ²ìÏÔʾ£¬¶«±±ÍíÄêȺÌ念½¡ÐÅÏ¢»ñÈ¡ÇþµÀ80%ÒÀÀµµçÊÓÑøÉú½ÚÄ¿£¬¶øÕâЩ½ÚĿרҵ¶È¼°¸ñÂʽö38%¡£ÄêÇáȺÌåÈÈÖÔµÄÖÇÄÜÒÂ×Å×°±¸ÆÕ¼°ÂÊÔÚ60ËêÒÔÉÏÈËȺÖÐȱ·¦7%£¬Êý×Ö¿µ½¡ºè¹µµÖ´ïÀúÊ··åÖµ¡£¸üΪÑÏËàµÄÊÇ£¬¹Å°å¼ÒÍ¥½á¹¹µÄ½âÌåʹµÃ26%¶À¾ÓÀÏÈËÈÕ¾ùÑÎÉãÈëÁ¿Áè¼Ý±ê×¼3.8¿Ë¶ø²»×ÔÖª¡£
ÆÆ¾Ö·¾¶£º¶àά¶È¿µ½¡ÉúÌ¬ÖØ¹¹
½â¾öÎÊÌâµÄÒªº¦ÔÚ¹¹½¨·Ö¼¶¿µ½¡¸ÉԤϵͳ¡£ÉòÑôÊÔµãÏîÄ¿Åú×¢£¬ÉçÇøÓªÑøÊ¦½éÈë¿ÉʹÍíÄêÈËÉÅʳ½á¹¹¸ÄÉÆÂÊ´ï63%¡£Í¬Ê±ÐèÒªÕûºÏ¹©Å¯ÆÚÊÒÄÚÔ˶¯¼Æ»®£¬¹þ¶û±õijÉçÇø¿ª·¢µÄÊÊÀϽ¡Éí²Ùʹ¼ÓÈëȺÌåÑüΧƽ¾ùËõ¼õ4.2ÀåÃס£Ò½ÁÆÏµÍ³·½Ã棬Զ³ÌÎÊÕïÆ½Ì¨ÁýÕÖÂʵÄÌáÉýʹÂýÐÔ²¡¸´ÕïЧÂÊÌá¸ß41%£¬ÓÐÓûº½âÒ½ÁÆ×ÊÔ´´íÅäÎÊÌâ¡£
Õâ´ÎÖйú¶«±±ÍíÄêȺÌ念½¡Î£»ú£¬ÊµÖÊÉÏÊdzÇÕò»¯Àú³ÌÖеÄ×ÛºÏÖÎÀí¿ÎÌâ¡£Êý¾ÝÏÔʾ£¬ÊµÑ鿵½¡¸ÉÔ¤µÄÉçÇøÒ½ÁÆÖ§³öϽµ19%£¬Ö¤ÊµÔ¤·ÀÐÔ¿µ½¡ÖÎÀí¾ßÓÐÏÔÖø¾¼Ã¼ÛÖµ¡£Î¨ÓÐÂòͨÕþ²ß±ÚÀÝ£¬½¨ÉèÎÀ½¡¡¢ÃñÕþ¡¢ÌåÓýµÈ²¿·ÖÐ×÷»úÖÆ£¬²Å»ªÕæÕý»¯½âÒþ²ØÓÚ·ÊÅÖÕ÷Ï󱳺óµÄϵͳÐÔΣº¦¡£Õâ²»µ«ÊÇÒ½ÁÆÏµÍ³µÄˢУ¬¸üÊÇÀÏÁ仯Éç»áÓ¦¶ÔÄÜÁ¦µÄÖÜȫĥÁ·¡£